The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer

British Journal of Cancer

Volumn 92, Issue 4, 2005, Pages 651-654

  Canna, K ^a   McArdle, P A ^a   McMillan, D C ^a   McNicol, A M ^a   Smith, G W ^a   McKee, R F ^a   McArdle, C S ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

C reactive protein; CD4+ and CD8+ T lymphocytes; Colorectal cancer; Survival

Indexed keywords

C REACTIVE PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR VOLUME; BLOOD; CANCER INVASION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLORECTAL TUMOR; IMMUNOLOGY; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; SURVIVAL;

AGED; C-REACTIVE PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; T-LYMPHOCYTES;

EID: 14944344603     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602419     Document Type: Article

References (23)

1. Ali AA, McMillan DC, Matalka II, McNicol AM, McArdle CS (2004) Tumour T-lymphocyte subset infiltration and tumour recurrence following curative resection for colorectal cancer. Eur J Surg Oncol 30: 292-295
2. Anderson JA, Dunnill MS (1965) Observations on the estimation of the quantity of emphysema in the lungs by the point-sampling method. Thorax 20: 462-466
3. Belluco C, Nitti D, Frantz M, Toppan P, Basso D, Plebani M, Lise M, Jessup JM (2000) Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann Surg Oncol 7: 133-138
4. Blay JY, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, Mercatello A, Ravault A, Tourani JM, Moskovtchenko JF (1992) Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 52: 3317-3322
5. Bromwich EJ, McArdle PA, Canna K, McMillan DC, McNicol A-M, Brown M, Aitchison M (2003) The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Br J Cancer 89: 1906-1908
6. Dukes CE, Bussey HJR (1958) The spread of rectal cancer and its effect on prognosis. Br J Cancer 12: 309-320
7. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340: 448-454
8. Jass JR, Love SB, Northover JM (1987) A new prognostic classification of rectal cancer. Lancet 1(8545): 1303-1306
9. Kinoshita T, Ito H, Miki C (1999) Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer 85: 2526-2531
10. Lewenhaupt A, Ekman P, Eneroth P, Nilsson B (1990) Tumour markers as prognostic aids in prostatic carcinoma. Br J Urol 66: 182-187
11. Lin EY, Pollard JW (2004) Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 90: 2053-2058
12. McArdle PA, Canna K, McMillan DC, McNicol AM, Campbell R, Underwood MA (2004a) The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer. Br J Cancer 91: 541-543
13. McArdle PA, McMillan DC, Sattar N, Wallace AM, Underwood MA (2004b) The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease. Br J Cancer 91: 1755-1757
14. McMillan DC, Canna K, McArdle CS (2003) Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90: 215-219
15. McMillan DC, Wotherspoon HA, Fearon KC, Sturgeon C, Cooke TG, McArdle CS (1995) A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170: 319-322
16. Miki C, Konishi N, Ojima E, Hatada T, Inoue Y, Kusunoki M (2004) C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci 49: 970-976
17. Naito Y, Saito K, Shiiba K, Ohuchi A, Saiqenji K, Naqura H, Ohtani H (1998) CD8+ T cells infiltrated within cancer cell nests as prognostic factor in human colorectal cancer. Cancer Res 58: 3491-3494
18. Nielsen HJ, Christensen IJ, Sorensen S, Moesgaard F, Brunner N (2000) Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol 7: 617-623
19. Nielsen HJ, Hansen U, Christensen IJ, Reimert CM, Brunner N, Moesgaard F, The RANX05 Study Group (1999) Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 189: 487-495
20. O'Byrne KJ, Dalgleish AG (2001) Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 85: 473-483
21. O'Gorman P, McMillan DC, McArdle CS (2000) Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 37: 36-40
22. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava PK, Kosma VM (1997) Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182: 318-324
23. Vakkila J, Lotze MT (2004) Inflammation and necrosis promote tumour growth. Nat Rev Immunol 4: 641-648